Microbiology Independent Research Journal (MIR Journal)

Advanced search

Cellular immune response in infected mice to NSP protein encoded by the negative strand NS RNA of influenza A virus


Influenza A virus belongs to a family of enveloped viruses with an RNA genome of negative polarity consisting of 8 RNA segments. The transcription of this RNA genome results in the synthesis of positive-sense mRNAs that translate up to 16 unique viral proteins with the help of splicing and translational shift mechanisms. The 8th NS segment encodes the NS1 protein (27 kDa), which is an active interferon antagonist, and the nuclear export protein NEP (14 kDa) through the standard negative polarity pathway. In addition, an alternative open reading frame for the synthesis of a third viral protein (NSP, negative-strand protein) by means of a direct translation of genome polarity RNA (the so-called positive polarity genome strategy) was identified in the NS segment. Since it is unknown as to whether the NSP protein can be synthesized in the infected organism post viral infection, the generation of spleen leucocytes specific to this protein was studied in mice after two sequential infections with influenza A viruses of H1N1 and H3N2 subtypes. It was found that leucocyte clones specifically recognizing a peptide domain in the central region of the NSP protein (amino acid positions 82-119) were generated in mice infected with influenza A viruses. In silico prediction has shown strong major histocompatibility complex-1 (MHC-I) and MHC-II specific epitopes in this central domain of the NSP. Comparative analysis of the influenza H3N2 viruses circulating in humans during 1968-2018 has shown high NSP variability, which was similar to that shown for the hemagglutinin (HA) and neuraminidase (NA) proteins. The highest variability was found to be in the N- and C-terminal parts of the NSP. These observations suggest that synthesis of the NSP protein occurs in infected animals and further support a bipolar (ambisense) strategy of the RNA genome of human influenza A virus.

About the Authors

O. P. Zhirnov
N. F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology; The Russian-German Academy of Medical and Biotechnological Sciences
Russian Federation

Oleg Zhirnov


T. E. Konakova
N. F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology
Russian Federation

D. Anhlan
Institute of Virology, Westfaelische Wilhelms-University Muenster

S. Ludwig
Institute of Virology, Westfaelische Wilhelms-University Muenster

E. I. Isaeva
N. F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology
Russian Federation


1. Pflug A, Lukarska M, Resa-Infante P, Reich S, Cusack S. Structural insights into RNA synthesis by the influenza virus transcription-replication machine. Virus Res 2017; 234, 103-17. doi: 10.1016/j.virusres.2017.01.013.

2. Dou D, Revol R, Ostbye H, Wang H, Daniels R. Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement. Front Immunol 2018; 9, 1581. doi: 10.3389/fimmu.2018.01581.

3. Baez M, Zazra JJ, Elliott RM, Young JF, Palese P. Nucleotide sequence of the influenza A/duck/ Alberta/60/76 virus NS RNA: conservation of the NS1/NS2 overlapping gene structure in a divergent influenza virus RNA segment. Virology 1981; 113(1), 397-402. PubMed PMID: 6927848.

4. Zhirnov OP, Poyarkov SV, Vorob’eva IV, Safonova OA, Malyshev NA, Klenk HD. Segment NS of influenza A virus contains an additional gene NSP in positivesense orientation. Dokl Biochem Biophys 2007; 414, 127-33. PubMed PMID: 17695319.

5. Beklemishev AB, Blinov VM, Vasilenko SK, Golovin S, Karginov VA. Synthesis, cloning and determination of the primary structure of a full-size DNA copy of fragment 8 from the influenza virus type A genome. Bioorg Khim 1985; 11(5), 641-5. PubMed PMID: 4038350.

6. Zhirnov OP, Vorobjeva IV, Saphonova OA, Poyarkov SV, Ovcharenko AV, Anhlan D, et al. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells. J Clin Virol 2009; 45(4), 322-33. doi: 10.1016/j.jcv.2009.05.030.

7. Zhirnov OP, Klenk HD. Integration of influenza A virus NSP gene into baculovirus genome and its expression in insect cells. Vopr Virusol 2010; 55(2), 4-8. PubMed PMID: 20455463.

8. Zhirnov OP, Akulich KA, Lipatova AV, Usachev EV. Negative-sense virion RNA of segment 8 (NS) of influenza a virus is able to translate in vitro a new viral protein. Dokl Biochem Biophys 2017; 473(1), 122-7. doi: 10.1134/S1607672917020090.

9. Clifford M, Twigg J, Upton C. Evidence for a novel gene associated with human influenza A viruses. Virol J 2009; 6, 198. doi: 10.1186/1743-422X-6-198.

10. Gong YN, Chen GW, Chen CJ, Kuo RL, Shih SR. Computational analysis and mapping of novel open reading frames in influenza A viruses. PLoS One 2014; 9(12), e115016. doi: 10.1371/journal.pone.0115016.

11. Yang CW, Chen MF. Uncovering the Potential Pan Proteomes Encoded by Genomic Strand RNAs of Influenza A Viruses. PLoS One 2016; 11(1), e0146936. doi: 10.1371/journal.pone.0146936.

12. Sabath N, Morris JS, Graur D. Is there a twelfth protein-coding gene in the genome of influenza A? A selection-based approach to the detection of overlapping genes in closely related sequences. J Mol Evol 2011; 73(5-6), 305-15. doi: 10.1007/s00239-011-9477-9.

13. Zhirnov OP, Klenk HD. Alterations in caspase cleavage motifs of NP and M2 proteins attenuate virulence of a highly pathogenic avian influenza virus. Virology 2009; 394(1), 57-63. doi: 10.1016/j.virol.2009.08.013.

14. Bhasin M, Raghava GP. A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes. J Biosci 2007; 32(1), 31-42. PubMed PMID: 17426378.

15. Jensen KK, Andreatta M, Marcatili P, Buus S, Greenbaum JA, Yan Z, et al. Improved methods for predicting peptide binding affinity to MHC class II molecules. Immunology 2018; 154(3), 394-406. doi: 10.1111/imm.12889.

16. Jameson BA, Wolf H. The antigenic index: a novel algorithm for predicting antigenic determinants. Comput Appl Biosci 1988; 4(1), 181-6. PubMed PMID: 2454713.

17. Zhong W, Reche PA, Lai CC, Reinhold B, Reinherz EL. Genome-wide characterization of a viral cytotoxic T lymphocyte epitope repertoire. J Biol Chem 2003; 278(46), 45135-44. doi: 10.1074/jbc.M307417200.

18. Hempel DM, Smith KA, Claussen KA, Perricone MA. Analysis of cellular immune responses in the peripheral blood of mice using real-time RT-PCR. J Immunol Methods 2002; 259(1-2), 129-38. PubMed PMID: 11730848.

19. Liu Y, Chia ZH, Liew J, Or SM, Phua KKL. Modulation of mRNA Translation and Cell Viability by Influenza A Virus Derived Nonstructural Protein 1. Nucleic Acid Ther 2018; 28(3), 200-8. doi: 10.1089/nat.2017.0712.

20. Panthu B, Terrier O, Carron C, Traversier A, Corbin A, Balvay L, et al. The NS1 Protein from Influenza Virus Stimulates Translation Initiation by Enhancing Ribosome Recruitment to mRNAs. J Mol Biol 2017; 429(21), 3334-52. doi: 10.1016/j.jmb.2017.04.007.

21. Nordholm J, Petitou J, Ostbye H, da Silva DV, Dou D, Wang H, et al. Translational regulation of viral secretory proteins by the 5’ coding regions and a viral RNA-binding protein. J Cell Biol 2017; 216(8), 2283-93. doi: 10.1083/jcb.201702102.

22. Jan E, Mohr I, Walsh D. A Cap-to-Tail Guide to mRNA Translation Strategies in Virus-Infected Cells. Annu Rev Virol 2016; 3(1), 283-307. doi: 10.1146/annurevvirology-100114-055014.

23. Hickman HD, Mays JW, Gibbs J, Kosik I, Magadan JG, Takeda K, et al. Influenza A Virus Negative Strand RNA Is Translated for CD8(+) T Cell Immunosurveillance. J Immunol 2018; 201(4), 1222-8. doi: 10.4049/jimmunol.1800586.

24. Nguyen M, Haenni AL. Expression strategies of ambisense viruses. Virus Res 2003; 93(2), 141-50. PubMed PMID: 12782362.


For citations:

Zhirnov O.P., Konakova T.E., Anhlan D., Ludwig S., Isaeva E.I. Cellular immune response in infected mice to NSP protein encoded by the negative strand NS RNA of influenza A virus. Microbiology Independent Research Journal (MIR Journal). 2019;6(1):18-27. (In Russ.)

Views: 193

ISSN 2500-2236 (Online)